Results 201 to 210 of about 77,746 (246)
Some of the next articles are maybe not open access.
▼Interferon beta-1a for multiple sclerosis
Drug and Therapeutics Bulletin, 1998In early 1996, we reviewed ▼interferon beta-1b (Betaferon - Schering Healthcare Limited), the first interferon beta to be introduced for the treatment of multiple sclerosis. The product was very expensive and the evidence for it offering real clinical advantage weak; we recommended that it should only be used as part of a clinical trial or detailed ...
openaire +2 more sources
Interferon-γ: teammate or opponent in the tumour microenvironment?
Nature Reviews Immunology, 2021Creg J Workman, Dario A A Vignali
exaly
Immunotherapy of cancer in 2012
Ca-A Cancer Journal for Clinicians, 2012Ahmad A Tarhini, Lisa H Butterfield
exaly